1van der Kamp HJ,Wit JM.Neonatal screening for congenital adrenal hyperplasia[J].Eur J Endocrinol,2004,151(suppl 3):S71-S75.
2Homma K,Hasegawa T,Takeshita E,et al.Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates[J].J Clin Endrocrinol Metab,2004,89(12):6087-6091.
3Lane DE.Polycystic ovary syndrome and its differential diagnosis[J].Obs Gynecol Survey,2006,61(2):125-135.
4van der Kamp HJ,Oudshoorn CG.Cutoff levels of 17-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight[J].J Clin Endocrinol Metab,2005,90(7):3904-3907.
5Speiser PW.Diagnosis and management of congenital adrenal hyperplasia[J].Expert Rev Endocrin Metab,2006,1(1):103-110.
6Pang S,Pollack MS,Marshall RN,et al.Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J].N Engl J Med,1990,322:111-115.
7Joint LWPES/ESPE CAH Working Group.Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins pediatric endocrine society and the european society for paediatric endocrinology[J].J Clin Endocrinol Metab,20002,87(9):4048-4053.
8New MI,Carison A,Obeid J,et al.Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies[J].J Clin Endrocrinol Metab,2001,86(12):5651-5657.
9Lajic S,Wedell A,Bui TH,et al.Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia[J].J Clin Endocrinol Metab,1998,83 (11):3872-3880.
10Khadilkar VV,Khadilkar AV,Maskati GB.Impact of availability of oral hydrocortisone on growth of children with CAH[J].India J Pediatr,2005,72(4):301-303.
